(Q53581879)

15 May 2018

title

Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects. (English)

1 reference

15 May 2018

1 reference

1 reference

Kyoung-Ah Kim

1

1 reference

15 May 2018

Pil-Whan Park

2

1 reference

15 May 2018

Ock-Je Lee

3

1 reference

15 May 2018

Dong-Kyun Kang

4

1 reference

15 May 2018

Ji-Young Park

5

1 reference

15 May 2018

publication date

1 January 2007

1 reference

15 May 2018

The Journal of Clinical Pharmacology

published in

1 reference

15 May 2018

volume

47

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

87-93

1 reference

15 May 2018

Pharmacogenomics: translating functional genomics into rational therapeutics

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Sex is a major determinant of CYP3A4 expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

A significant drug-metabolizing role for CYP3A5?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Lipid-lowering response to statins is affected by CYP3A5 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Clinical pharmacokinetics and practical applications of simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006295063

21 January 2018

Identifiers

DOI

10.1177/0091270006295063

1 reference

15 May 2018

1 reference

15 May 2018